Opinion

Video

Patient Selection Criteria for Different Versions of Abiraterone Acetate in mCRPC

Author(s):

Jose De La Cerda III, MD, MPH

This video segment discusses patient selection criteria for choosing between the original brand, generic, and micronized versions of abiraterone.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Video content above is prompted by the following:

      • Can you share your patient selection criteria for different versions of abiraterone?
      Related Videos
      1 expert in this video
      Clinical Benefits of BPH Treatments
      1 expert in this video
      BPH Management: Patient Outcome Evolution
      Final Thoughts and Clinical Trials in NMIBC
      Final Thoughts and Clinical Trials in NMIBC
      Uptake of New Treatments in Urology Practice
      Uptake of New Treatments in Urology Practice
      Patient Communication and Treatment Adherence in NMIBC
      Patient Communication and Treatment Adherence in NMIBC
      1 expert in this video
      Resective Surgery and Minimally Invasive Procedures For BPH
      Operationalizing TAR-200 and Other Delivery Systems in Practice
      Operationalizing TAR-200 and Other Delivery Systems in Practice
      Unmet Needs in NMIBC
      Unmet Needs in NMIBC
      Checkpoint Inhibitors for Treatment of NMIBC
      Checkpoint Inhibitors for Treatment of NMIBC
      Communication of Treatment Options for High-Risk NMIBC
      Communication of Treatment Options for High-Risk NMIBC
      Related Content
      © 2025 MJH Life Sciences

      All rights reserved.